Management of vasoplegia after cardiopulmonary bypass: role of prostaglandin inhibition.
Augoustides
John G T
JG
D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D006801:Humans; D011448:Prostaglandin Antagonists / Q000627:therapeutic use*; D012769:Shock / Q000188:drug therapy*; D014652:Vascular Diseases / Q000188:drug therapy*
D011448:Prostaglandin Antagonists